Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junichi Taki

Showing results (1-10 of 106) with videos related to

Pageof 11
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 9, 2003
[99mTc-PYP scintigraphy: its usefulness and pitfalls]Junichi Taki, Kenichi Nakajima
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 9, 2003
[Advance in nuclear cardiology and radiopharmaceuticals]Junichi Taki, Hisashi Buko
European Journal of Nuclear Medicine and Molecular Imaging|May 5, 2007
Metabolic imaging using SPECTJunichi Taki, Ichiro Matsunari
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 7, 2002
Sequential strategy using multimodality viability tests: does it work?Ichiro Matsunari, Junichi Taki, Norihisa Tonami
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 9, 2003
[Myocardial fatty acid imaging with I-123 BMIPP]Kenichi Nakajima, Junichi Taki, Norihisa Tonami
Clinical Nuclear Medicine|October 7, 2011
Tc-99m human serum albumin lymphoscintigraphy with SPECT/CT in chylothoraxDaiki Kayano, Junichi Taki, Hiroshi Wakabayashi, et al.
Clinical Nuclear Medicine|December 16, 2010
Comparison of diagnostic value of I-123 MIBG and high-dose I-131 MIBG scintigraphy including incremental value of SPECT/CT over planar image in patients with malignant pheochromocytoma/paraganglioma and neuroblastomaMakoto Fukuoka, Junichi Taki, Takafumi Mochizuki, et al.
Annals of Nuclear Medicine|November 2, 2004
Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders: it can be a specific marker for Lewy body diseaseJunichi Taki, Mitsuhiro Yoshita, Masahito Yamada, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 18, 2005
(99m)Tc-tetrofosmin as a prognostic agent?Ichiro Matsunari, Junichi Taki, Kenichi Nakajima, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 28, 2010
123I-metaiodobenzylguanidine imaging in the era of implantable cardioverter defibrillators: beyond ejection fractionIchiro Matsunari, Junichi Taki, Kenichi Nakajima, et al.
Pageof 11

Showing results (1-10 of 106) with videos related to

Sort By:
Pageof 11
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 9, 2003
[99mTc-PYP scintigraphy: its usefulness and pitfalls]Junichi Taki, Kenichi Nakajima
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 9, 2003
[Advance in nuclear cardiology and radiopharmaceuticals]Junichi Taki, Hisashi Buko
European Journal of Nuclear Medicine and Molecular Imaging|May 5, 2007
Metabolic imaging using SPECTJunichi Taki, Ichiro Matsunari
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 7, 2002
Sequential strategy using multimodality viability tests: does it work?Ichiro Matsunari, Junichi Taki, Norihisa Tonami
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 9, 2003
[Myocardial fatty acid imaging with I-123 BMIPP]Kenichi Nakajima, Junichi Taki, Norihisa Tonami
Clinical Nuclear Medicine|October 7, 2011
Tc-99m human serum albumin lymphoscintigraphy with SPECT/CT in chylothoraxDaiki Kayano, Junichi Taki, Hiroshi Wakabayashi, et al.
Clinical Nuclear Medicine|December 16, 2010
Comparison of diagnostic value of I-123 MIBG and high-dose I-131 MIBG scintigraphy including incremental value of SPECT/CT over planar image in patients with malignant pheochromocytoma/paraganglioma and neuroblastomaMakoto Fukuoka, Junichi Taki, Takafumi Mochizuki, et al.
Annals of Nuclear Medicine|November 2, 2004
Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders: it can be a specific marker for Lewy body diseaseJunichi Taki, Mitsuhiro Yoshita, Masahito Yamada, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 18, 2005
(99m)Tc-tetrofosmin as a prognostic agent?Ichiro Matsunari, Junichi Taki, Kenichi Nakajima, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 28, 2010
123I-metaiodobenzylguanidine imaging in the era of implantable cardioverter defibrillators: beyond ejection fractionIchiro Matsunari, Junichi Taki, Kenichi Nakajima, et al.
Pageof 11